Don't get me wrong, I know Covaris is the best for its job. But if you have a small budget and no genomic center around, can you get around it by using enzymes, even just DNase I. What is the pros and cons of doing that? Thanks.
Unconfigured Ad
Collapse
X
-
You can do the job with enzymes (NEB fragmentase or something) at the cost of a broader size distribution. You'd need to do a gel-cut size selection most likely, and you'll need some extra initial sample to compensate for the fact that a lot of the sheared DNA will probably fall outside your desired size range. Nonetheless, if you can put up with that your library quality should still be fine.
Comment
-
-
Have you looked into Nextera library prep?
It's much cheaper through Illumina than it was through EpiCentre and it works well for us. Still not as cheap as standard preps, but it saves on having to spend on a Covaris - not cost effective if your throughput is low....and it's much, much quicker.
Comment
-
-
Thank you all for the reply.
TonyBrooks, how is the size range of Nextera prep? Do you need to do a gel-cut size selection afterward? Can you produce library with different size? e.g., 200bp, 400bp. It make sense that Nextera combine the fragmentation and adapter adding in the same step, which may increase the yield of the library. Have you seen that in your experience? Finally, how much the kit cost? I can't find out the price even after I register on Illumina webpage. Sorry for so many questions. I appreciate your advice.
Comment
-
-
You do get a large size distribution (250-1000bp) but this is sufficient for us. Most distributions are tighter than that when looking at the sequencing. You could always augment the reaction with a gel-cut as in regular sample prep. You might be able to add more starting material to compensate for the loss of material from the gel excision.
Comment
-
-
I'm not saying you can't do it, just that it's not officially supported by Illumina (certainly for TruSeq enrichment, not sure about Agilent and Nimblegen).
With the correct blocking sequences, you should be able to cobble something together. You also probably wouldn't need to gel-cut as target enrichment seems to create tighter libraries.
Comment
-
-
Hi Cli,
I think the investment in sample preparation is sometimes overlooked in NGS which can lead to more work, sample loss, and adverse effects on the quality of data obtained.
While comparing other shearing methodologies it is important to consider the following:
1. time and work required to optimize the shearing process. Covaris does have validated optimized settings for all size ranges from 100bp-5kb. These settings are practically concentration independent.
2. sample loss. how precious are you samples. no direct contact with the sample, so no sample loss, and no worry for contamination.
3. flexibility in shearing size range.
4. reproducibility. The Covaris instruments are hard wire calibrated in the factory, so absolutely no calibration required. All Covaris protocols will generate the same size range of interest on any of the instruments in any lab.
5. Thermal damage/sequence bias. isothermal processing achieved with the Covaris, so no worry for thermal damage, or thermal biased fragmentation.
6. Size selection prior to library preparation. With Covaris shearing the fragment distribution is tight enough so that you do not have to do size selection for quite a few of the library preparation protocols.
If you do have budgetary concerns, there are two options from Corvaris:
1. Use the Covaris shearing service.
2. wait for the upcoming release of the Covaris M220 which is a low cost shearing instrument from Covaris specifically designed for DNA shearing for low throughput labs.
Thank you
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 12:17 PM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
Today, 12:17 PM
|
||
|
Started by SEQadmin2, Yesterday, 11:41 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment